Why the study?
Does moxonidine as an add-on agent improve blood pressure control and tolerability in hypertensive patients in primary care?
Does moxonidine as an add-on agent improve blood pressure control and tolerability in hypertensive patients in primary care?
Moxonidine is an effective and well-tolerated add-on antihypertensive agent in real-world primary care settings.
No takes yet. Share an insight, caveat, or question.
May support moxonidine as add-on in primary care hypertension; hypothesis-generating, requires randomized confirmation.
Schachter et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: